Correlation Between Inhibrx and Foghorn Therapeutics

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Foghorn Therapeutics, you can compare the effects of market volatilities on Inhibrx and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Foghorn Therapeutics.

Diversification Opportunities for Inhibrx and Foghorn Therapeutics

0.4

Correlation Coefficient

Inhibrx  Foghorn Therapeutics

Very weak diversification

The 3 months correlation between Inhibrx and Foghorn is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Foghorn Therapeutics go up and down completely randomly.

Pair Corralation between Inhibrx and Foghorn Therapeutics

Given the investment horizon of 90 days Inhibrx is expected to generate 10.51 times less return on investment than Foghorn Therapeutics. But when comparing it to its historical volatility, Inhibrx is 1.79 times less risky than Foghorn Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  785.00  in Foghorn Therapeutics on August 31, 2024 and sell it today you would lose (6.00) from holding Foghorn Therapeutics or give up 0.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Inhibrx  vs.  Foghorn Therapeutics

Inhibrx

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Foghorn Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Foghorn Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Foghorn Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Inhibrx and Foghorn Therapeutics

The main advantage of trading using opposite Inhibrx and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.

The idea behind Inhibrx and Foghorn Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.